DBV Technologies | DBVT - Vermögenswerte

Aktienkurs
21.72
Täglich Wechseln
-1.07 -4.70%
Monatlich
1.21%
Jährlich
389.19%
Q1 Prognose
20.46




Vermögenswerte Veränderung Datum
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Amarin USD 659.81M 10.31M 2025-09
BioCryst Pharmaceuticals USD 446.42M 10.76M 2025-09
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
DBV Technologies USD 110.49M 32.93M 2025-09
Esperion Therapeutics USD 364.02M 16.93M 2025-09
Galectin Therapeutics USD 27.65M 1.76M 2024-06
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Insmed USD 2.26B 96.18M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
PTC Therapeutics USD 2.9B 255.07M 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
United Therapeutics USD 7.88B 528.9M 2025-12